首个上海国际生物医药产业周于2021年10月11日-14日举行，来凯医药积极参与了多项活动，包括产业周开幕式、张江生命科学国际创新峰会、摩根大通全球医疗健康产业年会上海论坛、张江生命科学PR/IR论坛等, 与学届、商界、业界积极互动交流。

作为上海的一家Biotech，来凯医药还在产业周期间受到媒体关注，新华社、中国日报、解放日报、文汇报、新民晚报、上视新闻、东方卫视、上海日报、学习强国app等都刊登了关于来凯医药的报道或观点。来凯青年科学家的实验室工作照及相关采访刊登在上海日报的头版头条和专题报道版面。

以下为报道节选：

Shanghai's biomedicine policy a shot in the arm for industry players

Shanghai's latest pledge to further boost the strategic biopharmaceutical industry received praise and warm response from various industry players.

The International Biopharma Industry Week of Shanghai kicked off on Monday, hosting dozens of forums and industry discussion panels under the theme "Striving Together, Shaping Tomorrow."

Last year, Shanghai's biopharmaceutical industry was valued at 600 billion yuan (US$92.3 billion) with a gross industrial output of 140 billion yuan.

A total of 18 of the top 20 global pharma giants and 17 out of the top 20 medical device companies have set up their businesses in the city.

By 2025, life science industries in Shanghai are expected to have a market size of 1.2 trillion yuan and manufacturing output at 280 billion yuan.

"A multi-layered talent supply for both research and other professional services is also vital for the development of the industry in the long run," said Li Jia, director general of the Shanghai Institute of Medicine of the Chinese Academy of Sciences.

The ability to offer truly innovative products is what sets Shanghai aside from other domestic cities since it has the presence of established firms, startups, research institutions and hospitals. The capability to be truly innovative is vital for a world-class industry cluster, he said.

A returnee and former scientist at Novartis China's research center, Lu Xiangyang is exactly the type of talent Shanghai wants to retain.

Lu, who is CEO and founder of the four-year-old company Laekna Therapeutics, said he's looking forward to seeking commercial partnership and financiers at the industry week.

"Many of my peers with similar work and research experience are coming to Shanghai thanks to a complete industry value chain covering research, manufacturing, commercial marketing, and sales," he said.

The company aims to file for approval of a new cancer-treatment drug by the end of next year.

Lu said he hopes that as the industry week becomes an annual event it will serve as a bridge linking local and overseas industry players with international influence.

A researcher works at Laekna Therapeutics's lab in Shanghai.